Email This Content
Send an email to a colleague about this document. Non-subscribers may purchase the article.© Copyright 2010 WINDHOVER INFORMATION INC., All Rights Reserved
Windhover Information Inc. - Health Care Business Intelligence
Delivering essential analysis and insights to top health care executives, investment professionals, and industry consultants
The Pink Sheet DAILY 10/26/2009
"The Pink Sheet" DAILY -- GlaxoSmithKline signed an option deal with the cancer specialist SuperGen to discover and develop cancer drugs based on epigenetic targets, SuperGen announced on Oct. 26.
100% Satisfaction Guarantee
If you are already a subscriber, please log in for complete access. 
Questions? Call (800) 332-2181
Click an article title to see a free preview.
Deals Of The Week: Sanofi/Micromet, Cephalon/BioAssets, GSK/SuperGen..., The Pink Sheet 11/2/2009
GSK Takes An Option On Concert's Preclinical Compounds, The Pink Sheet DAILY 6/2/2009
